ArticleNature communications2025

Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.

Mathieu Ferrari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.